Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
Saved in:
Main Authors: | Can G. Leineweber (Author), Miriam Rabehl (Author), Anne Pietzner (Author), Nadine Rohwer (Author), Michael Rothe (Author), Maciej Pech (Author), Bruno Sangro (Author), Rohini Sharma (Author), Chris Verslype (Author), Bristi Basu (Author), Christian Sengel (Author), Jens Ricke (Author), Nils Helge Schebb (Author), Karsten-H. Weylandt (Author), Julia Benckert (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
by: Can G. Leineweber, et al.
Published: (2023) -
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
by: Nils Helge Schebb, et al.
Published: (2022) -
"The magic triangle between bed, office, couch": a qualitative exploration of job demands, resources, coping, and the role of leadership in remote work during the COVID-19 pandemic
by: Elisabeth Rohwer, et al.
Published: (2024) -
Integration of care for hypertension and diabetes: a scoping review assessing the evidence from systematic reviews and evaluating reporting
by: Kristy C Yiu, et al.
Published: (2018) -
Illegitimate work tasks: an investigation of psychometric properties of the Swedish version of the BITS instrument and its suitability in human versus 'non-human' service occupations
by: Johanna Stengård, et al.
Published: (2024)